Americans brace for higher costs as Big Pharma defies Trump, hikes prices on 350 medicines

Drugmakers raise US prices on 350 medicines despite pressure from Trump

Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump

Drugmakers plan to raise US prices on at least 350 medications: Report

The cost of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump administ…

Pharma companies defy Trump's pressure with latest move — and it will impact most Americans

The prices of 350 drugs will be increased by some notable companies like Pfizer and Sanofi.

Americans brace for higher costs as Big Pharma defies Trump, hikes prices on 350 medicines

US pharmaceutical firms plan to increase list prices on at least 350 branded medicines in 2026, including key Covid vaccines and cancer drug Ibrance, despite pressure from the Trump administration for reductions.

Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines

NEW YORK, Jan 3, 2026, 13:21 ET — Market closed Drugmakers are lifting U.S. list prices on hundreds of medicines as 2026 begins, putting drug-pricing politics back in focus for healthcare investors. The sector finished higher in Friday’s session, the last U.S. trading day before the weekend. Drugmakers plan to raise U.S. prices on at least 350 branded medicines for 2026, including vaccines for COVID-19, RSV and shingles, as well as Pfizer’s canc…

US Drug Prices to Climb Again in 2026, Affecting 350 Branded Medicines

U.S. drugmakers plan to raise prices on 350 medicines in 2026, affecting vaccines and major treatments despite pressure to cut costs.